Catalog No.
PVV15301
Species reactivity
Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant EBV/HHV4 EBNA1/BKRF1 (His468-Pro607).
Tested applications
ELISA: 1:4000-1:8000, WB: 1:1000-1:4000
Target
Epstein-Barr nuclear antigen 1, EBNA-1, EBV nuclear antigen 1, EBNA1, BKRF1
Purification
Purified by antigen affinity column.
Accession
P03211
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Inhibitory effect of recombinant BCG containing the fusion gene BFNA on EB virus-positive tumors., PMID:40459582
Virus-specific antibody responses in multiple sclerosis patients treated with Ocrevus., PMID:40398376
Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta., PMID:40372913
Paediatric autoimmune uveitis is associated with intraocular antibodies against Epstein-Barr virus Nuclear Antigen 1 (EBNA-1)., PMID:40239467
Co-infections and Reactivation of some Herpesviruses (HHV) and Measles Virus (MeV) in Egyptian Cancer Patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)., PMID:40214827
Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals., PMID:40157431
Strong association with remote EBV infection in children with MS as opposed to other acquired demyelinating disorders., PMID:40102037
Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls., PMID:40063790
A Bidirectional Mendelian Randomization Study on the Causal Relationship Between Epstein-Barr Virus Antibodies and Prostate Cancer Risk., PMID:40026212
SFRP2 mediates Epstein-Barr virus and bladder cancer risk: a Mendelian randomization study and colocalization analysis., PMID:40016549
Genetic evidence identifies a causal relationship between EBV infection and multiple myeloma risk., PMID:39984542
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas., PMID:39908567
Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest., PMID:39879169
Exploring bidirectional causal relationships between antibody-mediated immune responses to infectious agents and systemic lupus erythematosus through Mendelian randomization and meta-analyses., PMID:39863087
EBV-specific T-cell immunity: relevance for multiple sclerosis., PMID:39776919
Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha crystalline beta., PMID:39763959
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis., PMID:39742283
Epstein-Barr virus infection in patients with MOGAD., PMID:39668776
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis., PMID:39666032
Epstein-Barr nuclear antigen 1 antibody-based indices are increased in patients with multiple sclerosis., PMID:39577298
Use of antibodies against Epstein-Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformation., PMID:39514105
Does Epstein-Barr virus and intracellular Toll-like receptors affect the course of Hashimoto disease? Findings from studies on newly-diagnosed patients., PMID:39508448
Evidence that autoantibody production may be driven by acute Epstein-Barr virus infection in Sjögren's disease., PMID:39472059
Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren's syndrome patient., PMID:39427375
Greater humoral EBV response may be associated with choroid plexus inflammation in progressive MS., PMID:39420132
Structure-based design of antibodies targeting the EBNA1 DNA-binding domain to block Epstein-Barr virus latent infection and tumor growth., PMID:39399647
TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice., PMID:39387189
Analysis of the epidemiology and clinical characteristics of Epstein-Barr virus infection., PMID:39380297
EBNA-1 antibody and autoimmune rheumatic diseases: A Mendelian Randomization Study., PMID:39286141
The Epstein-Barr Virus Nuclear Antigen 1 Variant Associated with Nasopharyngeal Carcinoma Defines the Sequence Criteria for Serologic Risk Prediction., PMID:39264275
Enhanced and cross-reactive in vitro memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosis., PMID:39257578
The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis., PMID:39244576
Cytomegalovirus and Epstein-Barr virus infections in patients with neuromyelitis optica spectrum disorder., PMID:39046523
Analysis of the Association Between Pathogen Exposure and the Risk of Dementia., PMID:38995782
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy., PMID:38921797
A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression., PMID:38911861
Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma., PMID:38894502
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study., PMID:38860471
Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis., PMID:38843296
Alzheimer's disease risk associated with changes in Epstein-Barr virus nuclear antigen 1-specific epitope targeting antibody levels., PMID:38824738
EBV and multiple sclerosis: expression of LMP2A in MS patients., PMID:38721048
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis., PMID:38630618
Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides., PMID:38547427
Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis., PMID:38497939
The Level of Anti-Viral Antigen-Specific Antibodies to EBNA-1 in the Serum of MS Patients Does not Depend on the Severity of the Disease., PMID:38472667
Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review., PMID:38401201
Antibody Profiling of Pan-Cancer Viral Proteome Reveals Biomarkers for Nasopharyngeal Carcinoma Diagnosis and Prognosis., PMID:38309569
The Relationship between Cancer Stage, Selected Immunological Parameters, Epstein-Barr Virus Infection, and Total Serum Content of Iron, Zinc, and Copper in Patients with Laryngeal Cancer., PMID:38256645
Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness., PMID:38254830
Can the Epstein-Barr Virus Play a Role in the Development of Prostate Cancer?, PMID:38254816
For research use only. Not for human or drug use.
